AAAAAA
Results:
1-24
|
Results: 24
Authors:
Lavelin, I
Meiri, N
Genina, O
Alexiev, R
Pines, M
Citation: I. Lavelin et al., Na+-K+-ATPase gene expression in the avian eggshell gland: distinct regulation in different cell types, AM J P-REG, 281(4), 2001, pp. R1169-R1176
Authors:
Pines, M
Citation: M. Pines, Bridging individual and group psychology - Discussion of Hopper's paper, GROUP, 25(3), 2001, pp. 191-194
Authors:
Bruck, R
Genina, O
Aeed, H
Alexiev, R
Nagler, A
Avni, Y
Pines, M
Citation: R. Bruck et al., Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats, HEPATOLOGY, 33(2), 2001, pp. 379-386
Authors:
Bruck, R
Shirin, H
Aeed, H
Matas, Z
Hochman, A
Pines, M
Avni, Y
Citation: R. Bruck et al., Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers, J HEPATOL, 35(4), 2001, pp. 457-464
Authors:
Pines, M
Domb, A
Ohana, M
Inbar, J
Genina, O
Alexiev, R
Nagler, A
Citation: M. Pines et al., Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone, BIOCH PHARM, 62(9), 2001, pp. 1221-1227
Authors:
Elkin, M
Miao, HQ
Nagler, A
Aingorn, E
Reich, R
Hemo, I
Dou, HL
Pines, M
Vlodavsky, I
Citation: M. Elkin et al., Halofuginone: a potent inhibitor of critical steps in angiogenesis progression, FASEB J, 14(15), 2000, pp. 2477-2485
Authors:
Pines, M
Citation: M. Pines, Shepherding group analysis: Shepherds past, present and future, GROUP, 24(1), 2000, pp. 49-57
Authors:
Pines, M
Vlodavsky, I
Nagler, A
Citation: M. Pines et al., Halofuginone: From veterinary use to human therapy, DRUG DEV R, 50(3-4), 2000, pp. 371-378
Authors:
Nagler, A
Pines, M
Abadi, U
Pappo, O
Zeira, M
Rabbani, E
Engelhardt, D
Ohana, M
Chowdhury, NR
Chowdhury, JR
Ilan, Y
Citation: A. Nagler et al., Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice, HEPATOLOGY, 31(3), 2000, pp. 641-648
Authors:
Praul, CA
Ford, BC
Gay, CV
Pines, M
Leach, RM
Citation: Ca. Praul et al., Gene expression and tibial dyschondroplasia, POULTRY SCI, 79(7), 2000, pp. 1009-1013
Authors:
Lavelin, I
Meiri, N
Pines, M
Citation: I. Lavelin et al., New insight in eggshell formation, POULTRY SCI, 79(7), 2000, pp. 1014-1017
Authors:
Nagler, A
Gofrit, O
Ohana, M
Pode, D
Genina, O
Pines, M
Citation: A. Nagler et al., The effect of halofuginone, an inhibitor of collagen type I synthesis, on urethral stricture formation: In vivo and in vitro study in a rat model, J UROL, 164(5), 2000, pp. 1776-1780
Authors:
Yarden, N
Lavelin, I
Genina, O
Hurwitz, S
Diaz, R
Brown, EM
Pines, M
Citation: N. Yarden et al., Expression of calcium-sensing receptor gene by avian parathyroid gland in vivo: Relationship to plasma calcium, GEN C ENDOC, 117(2), 2000, pp. 173-181
Authors:
Uni, Z
Zaiger, G
Gal-Garber, O
Pines, M
Rozenboim, I
Reifen, R
Citation: Z. Uni et al., Vitamin A deficiency interferes with proliferation and maturation of cellsin the chicken small intestine, BR POULT SC, 41(4), 2000, pp. 410-415
Authors:
Ilan, Y
Gotsman, I
Pines, M
Beinart, R
Zeira, M
Ohana, M
Rabbani, E
Engelhardt, D
Nagler, A
Citation: Y. Ilan et al., Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model, BLOOD, 95(11), 2000, pp. 3613-3619
Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone
Authors:
Elkin, M
Reich, R
Nagler, A
Aingorn, E
Pines, M
de-Groot, N
Hochberg, A
Vlodavsky, I
Citation: M. Elkin et al., Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone, CLIN CANC R, 5(8), 1999, pp. 1982-1988
Authors:
Pines, M
Citation: M. Pines, The adaptive design of the human psyche. Psychoanalysis, evolution in biology and the therapeutic process., ISR J PSYCH, 36(4), 1999, pp. 303-304
Authors:
Ben-Bassat, S
Genina, O
Lavelin, I
Leach, RM
Pines, M
Citation: S. Ben-bassat et al., Parathyroid receptor gene expression by epiphyseal growth plates in rickets and tibial dyschondroplasia, MOL C ENDOC, 149(1-2), 1999, pp. 185-195
Authors:
Nagler, A
Pines, M
Citation: A. Nagler et M. Pines, Topical treatment of cutaneous chronic graft versus host disease with halofuginone - A novel inhibitor of collagen type I synthesis, TRANSPLANT, 68(11), 1999, pp. 1806-1809
Authors:
Wang, YC
Spatz, MK
Kannan, K
Hayk, H
Avivi, A
Gorivodsky, M
Pines, M
Yayon, A
Lonai, P
Givol, D
Citation: Yc. Wang et al., A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3, P NAS US, 96(8), 1999, pp. 4455-4460
Authors:
Elkin, M
Ariel, I
Miao, HQ
Nagler, A
Pines, M
de-Groot, N
Hochberg, A
Vlodavsky, I
Citation: M. Elkin et al., Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone, CANCER RES, 59(16), 1999, pp. 4111-4118
Authors:
Nagler, A
Genina, O
Lavelin, I
Ohana, M
Pines, M
Citation: A. Nagler et al., Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model, AM J OBST G, 180(3), 1999, pp. 558-563
Authors:
Pines, M
Citation: M. Pines, Great Britain, CHALLENGE FOR PSYCHOANALYSIS AND PSYCHOTHERAPY, 1999, pp. 15-27
Authors:
Lavelin, I
Yarden, N
Ben-Bassat, S
Bar, A
Pines, M
Citation: I. Lavelin et al., Regulation of osteopontin gene expression during egg shell formation in the laying hen by mechanical strain, MATRIX BIOL, 17(8-9), 1998, pp. 615-623
Risultati:
1-24
|